Hikma Pharmaceuticals Partners with Emergent BioSolutions for KLOXXADO® Naloxone Nasal Spray Distribution Hikma Pharmaceuticals has entered into an exclusive agreement with Emergent BioSolutions to market KLOXXADO® naloxone nasal spray, enhancing access to opioid overdose treatment in North America.

Hikma Pharmaceuticals Partners with Emergent BioSolutions for KLOXXADO® Naloxone Nasal Spray Distribution #London #United_Kingdom #Hikma #KLOXXADO #Emergent_BioSolutions